3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Completed
2
Unknown
1
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
129
Thoracic
13
Genitourinary
13
Breast
7
Sarcoma
6
Head & Neck
6
Gynecologic
6
Dermatologic
6
Other solid neoplasm
4
CNS
4
Endocrine
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Multiple Myeloma
477
Neoplasms, Plasma Cell
102
Lymphoma
86
Lymphoma, Non-Hodgkin
75
Leukemia, Lymphocytic, Chronic, B-Cell
72
Myelodysplastic Syndromes
71
Recurrence
68
Leukemia, Myeloid, Acute
68
Leukemia
68
Precursor Cell Lymphoblastic Leukemia-Lymphoma
67
Hodgkin Disease
66
Lymphoma, Mantle-Cell
53
Lymphoma, Large B-Cell, Diffuse
53
Lymphoma, Follicular
45
Myeloproliferative Disorders
43
Neoplasms
41
Lymphoma, B-Cell, Marginal Zone
41
Burkitt Lymphoma
41
Primary Myelofibrosis
38
Lymphoma, Large-Cell, Immunoblastic
36
Lymphoma, T-Cell, Cutaneous
31
Leukemia, Myelomonocytic, Chronic
31
Sezary Syndrome
29
Mycosis Fungoides
29
Leukemia, Myeloid, Chronic-Phase
29
Leukemia, Myeloid, Accelerated Phase
29
Congenital Abnormalities
29
Leukemia, Hairy Cell
27
Blast Crisis
27
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Liver Neoplasms
×
Plasma cell
×
Clear all
NCT02900248
2019-04-02
N1
CureOne
Terminated
23 enrolled